If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
25th Feb 20161:15 pmRNSNet Asset Value(s)
25th Feb 201610:30 amRNSNet Asset Value(s)
24th Feb 20166:33 pmRNSResults of EGM and Cash Exit
18th Feb 20162:30 pmRNSUpdate re Return of Capital
18th Feb 201612:30 pmRNSNet Asset Value(s)
18th Feb 20169:45 amRNSHolding(s) in Company
12th Feb 20166:30 pmRNSCorrection to Form of Proxy
10th Feb 20165:30 pmRNSNet Asset Value(s)
9th Feb 20162:15 pmRNSNet Asset Value(s)
8th Feb 20164:10 pmRNSPublication of Circular
4th Feb 20164:15 pmRNSNet Asset Value(s)
4th Feb 201610:00 amRNSDirectorate Change
2nd Feb 20162:00 pmRNSUpdate on Continuation Proposals
29th Jan 20166:00 pmRNSTotal Voting Rights
27th Jan 201612:01 pmRNSHolding(s) in Company
27th Jan 201611:50 amRNSNet Asset Value(s)
25th Jan 20162:30 pmRNSUpdate on Continuation Proposals
21st Jan 20165:20 pmRNSNet Asset Value(s)
14th Jan 201611:00 amRNSNet Asset Value(s)
14th Jan 20167:00 amRNSUpdate on Continuation Proposals
12th Jan 201612:00 pmRNSTotal Voting Rights - Corrective Announcement
6th Jan 20164:45 pmRNSNet Asset Value(s)
4th Jan 20167:00 amRNSTotal Voting Rights
31st Dec 20151:30 pmRNSDirector's Other Directorship
30th Dec 20156:00 pmRNSNet Asset Value(s)
23rd Dec 20155:00 pmRNSNet Asset Value(s)
22nd Dec 201512:00 pmRNSNet Asset Value(s)
17th Dec 20157:00 amRNSFACTSHEET - NOVEMBER 2015
16th Dec 20153:30 pmRNSNet Asset Value(s)
10th Dec 20157:00 amRNSNet Asset Value(s)
9th Dec 20155:30 pmRNSUpdate on Proposed Return of Capital
8th Dec 20156:30 pmRNSHolding(s) in Company
3rd Dec 20156:20 pmRNSNet Asset Value(s)
3rd Dec 20155:30 pmRNSHolding(s) in Company
3rd Dec 20155:30 pmRNSHolding(s) in Company
3rd Dec 20154:00 pmRNSConversion between share classes
2nd Dec 20154:05 pmRNSUpdate on Proposed Return of Capital
1st Dec 20151:20 pmRNSReturn of Capital
1st Dec 201512:15 pmRNSTotal Voting Rights
30th Nov 20155:40 pmRNSTransaction in Own Shares
27th Nov 20156:20 pmRNSTransaction in Own Shares
26th Nov 20155:30 pmRNSTransaction in Own Shares
25th Nov 20155:40 pmRNSTransaction in Own Shares
25th Nov 20151:45 pmRNSNet Asset Value(s)
24th Nov 20155:45 pmRNSTransaction in Own Shares
23rd Nov 20155:45 pmRNSTransaction in Own Shares
20th Nov 20155:30 pmRNSTransaction in Own Shares
20th Nov 20153:15 pmRNSNet Asset Value(s)
20th Nov 20157:00 amRNSStatement re Continuation Vote
19th Nov 20156:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.